SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 94.94   3.17 (+3.45%) Volume: 317.67k 4:00 PM EDT 16-Aug-2019
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities108/13/2019
S-8Securities offered to employees under employee benefit plans1308/08/2019
10-QQuarterly report with a continuing view of a company's financial position4808/08/2019
4Statement of changes in beneficial ownership of securities108/06/2019
4Statement of changes in beneficial ownership of securities108/06/2019
4Statement of changes in beneficial ownership of securities108/05/2019
4Statement of changes in beneficial ownership of securities108/05/2019
4Statement of changes in beneficial ownership of securities108/05/2019
4Statement of changes in beneficial ownership of securities108/01/2019
4Statement of changes in beneficial ownership of securities107/31/2019
4Statement of changes in beneficial ownership of securities107/31/2019
8-KReport of unscheduled material events or corporate changes.1407/30/2019
8-KReport of unscheduled material events or corporate changes.407/24/2019
8-KReport of unscheduled material events or corporate changes.407/03/2019
4Statement of changes in beneficial ownership of securities107/02/2019
<<
First
<
Prev
123456789101112131415